• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因突变对肥厚型心肌病左心室心肌力学及纤维化模式的影响。

Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy.

作者信息

Kim Minjeong, Kim Yoonjung, Chung Hyemoon, Seo Jiwon, Park Chul Hwan, Kim Tae Hoon, Rim Se-Joong, Lee Kyung-A, Choi Eui-Young

机构信息

Division of Cardiology, Ewha Woman's University Mokdong Hospital, Seoul, Republic of Korea.

Department of Laboratory Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-Ro, Gangnam-Gu, Seoul, 06273, Republic of Korea.

出版信息

Sci Rep. 2025 Jan 4;15(1):799. doi: 10.1038/s41598-025-85201-0.

DOI:10.1038/s41598-025-85201-0
PMID:39755839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11700167/
Abstract

Myocyte disarray and fibrosis are underlying pathologies of hypertrophic cardiomyopathy (HCM) caused by genetic mutations. However, the extent of their contributions has not been extensively evaluated. In this study, we investigated the effects of genetic mutations on myofiber function and fibrosis patterns in HCM. A total of 133 patients with HCM underwent chamber geometry, late gadolinium enhancement (LGE), and T1-mapping evaluation using 1.5T cardiac magnetic resonance (CMR) imaging, echo-derived diastolic function analyses, and genetic testing. Left ventricular (LV) segmental and global longitudinal strain (LS), circumferential strain (CS), and rotation were measured using feature tracking analysis. Patients with sarcomere-associated mutation (SM, n = 41) exhibited lower LV-CS (all three slices) and higher basal rotation, along with a higher prevalence of midepicardial LGE. The relationship between SM and LV-CS was independent of LGE amount (ß = 0.239, p = 0.008). However, global LS and E/e' were not correlated with SM but were associated with LV mass index and LGE extent. SM was significantly correlated with the presence of midepicardial LGE (odds ratio 5.81, 95% confidence interval 2.15-15.72, p = 0.001), independent of LV mass index, hypertrophy pattern and E/e'. Augmented LV basal segmental rotation was significantly associated with dynamic obstruction. Circumferential fiber dysfunction and midepicardial fibrosis were related to SM, independent of the extent of LV hypertrophy. However, longitudinal fiber function was correlated to the extent of hypertrophy and fibrosis, regardless of SM. Subendocardial fibrosis did not show a significant association with SM.

摘要

心肌细胞排列紊乱和纤维化是由基因突变引起的肥厚型心肌病(HCM)的潜在病理特征。然而,它们的作用程度尚未得到广泛评估。在本研究中,我们调查了基因突变对HCM中肌纤维功能和纤维化模式的影响。共有133例HCM患者接受了1.5T心脏磁共振(CMR)成像的腔室几何形态、延迟钆增强(LGE)和T1映射评估、超声心动图衍生的舒张功能分析以及基因检测。使用特征跟踪分析测量左心室(LV)节段性和整体纵向应变(LS)、圆周应变(CS)和旋转。肌节相关突变(SM,n = 41)的患者表现出较低的LV-CS(所有三个层面)和较高的基底旋转,以及心外膜中层LGE的较高患病率。SM与LV-CS之间的关系独立于LGE量(β = 0.239,p = 0.008)。然而,整体LS和E/e'与SM无关,但与LV质量指数和LGE范围相关。SM与心外膜中层LGE的存在显著相关(优势比5.81,95%置信区间2.15-15.72,p = 0.001),独立于LV质量指数、肥厚模式和E/e'。增强的LV基底节段旋转与动态梗阻显著相关。圆周纤维功能障碍和心外膜中层纤维化与SM相关,独立于LV肥厚程度。然而,纵向纤维功能与肥厚和纤维化程度相关,与SM无关。心内膜下纤维化与SM未显示出显著关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9906/11700167/fcc797979fb3/41598_2025_85201_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9906/11700167/fcc797979fb3/41598_2025_85201_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9906/11700167/fcc797979fb3/41598_2025_85201_Fig1_HTML.jpg

相似文献

1
Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy.基因突变对肥厚型心肌病左心室心肌力学及纤维化模式的影响。
Sci Rep. 2025 Jan 4;15(1):799. doi: 10.1038/s41598-025-85201-0.
2
Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.在肥厚型心肌病中,左心房纤维化与左心室心肌延迟强化程度及左心室应变相关。
Int J Cardiovasc Imaging. 2019 Jul;35(7):1309-1318. doi: 10.1007/s10554-019-01551-7. Epub 2019 Feb 21.
3
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.应用三维斑点追踪超声心动图研究心肌整体和局部力学与肥厚型心肌病心肌肥厚和纤维化的关系。
Circ Cardiovasc Imaging. 2014 Jan;7(1):11-9. doi: 10.1161/CIRCIMAGING.113.000842. Epub 2013 Nov 25.
4
Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.肥厚型心肌病的收缩期和舒张期心肌力学及其与肥厚程度、替代性纤维化和间质纤维化的关系。
Int J Cardiovasc Imaging. 2015 Dec;31(8):1603-10. doi: 10.1007/s10554-015-0720-0. Epub 2015 Jul 26.
5
Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.肌节和线粒体相关突变对肥厚型心肌病患者心肌纤维化的影响。
J Cardiovasc Magn Reson. 2021 Mar 4;23(1):18. doi: 10.1186/s12968-021-00718-3.
6
Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.心脏淀粉样变性及其模仿疾病患者中CMR测量的纵向应变模式及其与延迟钆增强的关联。
J Cardiovasc Magn Reson. 2017 Aug 7;19(1):61. doi: 10.1186/s12968-017-0376-0.
7
Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.用于检测小儿肥厚型心肌病中心肌纤维化的新型心脏磁共振特征追踪(CMR-FT)分析
Pediatr Cardiol. 2016 Apr;37(4):663-73. doi: 10.1007/s00246-015-1329-8. Epub 2016 Jan 30.
8
Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.肥厚型心肌病病程中的左心房功能:与左心室肥厚及纤维化的关系
Invest Radiol. 2017 Mar;52(3):177-185. doi: 10.1097/RLI.0000000000000326.
9
Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.心血管磁共振特征追踪应变分析在鉴别高血压性心脏病与肥厚型心肌病中的应用。
PLoS One. 2019 Aug 21;14(8):e0221061. doi: 10.1371/journal.pone.0221061. eCollection 2019.
10
Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.心血管磁共振特征追踪技术评估肥厚型心肌病整体心肌力学的预后意义。与左心室肥厚和纤维化的关系。
Int J Cardiol. 2017 Dec 15;249:467-472. doi: 10.1016/j.ijcard.2017.07.087.

引用本文的文献

1
Genetic insights into hypertrophic cardiomyopathy: pathogenesis, diagnosis, and therapeutic implications.肥厚型心肌病的遗传学见解:发病机制、诊断及治疗意义
J Cardiovasc Imaging. 2025 Jul 21;33(1):9. doi: 10.1186/s44348-025-00055-4.

本文引用的文献

1
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2024 AHA/ACC/AMSSM/HRS/PACES/SCMR 肥厚型心肌病管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2024 Jun 4;149(23):e1239-e1311. doi: 10.1161/CIR.0000000000001250. Epub 2024 May 8.
2
SARC Gene Mutation Is Associated With Myocardial Fibrosis Measured by Histopathology and Cardiac Magnetic Resonance in Patients With Hypertrophic Cardiomyopathy.SARC 基因突变与肥厚型心肌病患者的心肌纤维化有关,该纤维化可通过组织病理学和心脏磁共振测量。
J Am Heart Assoc. 2023 Mar 7;12(5):e028293. doi: 10.1161/JAHA.122.028293. Epub 2023 Feb 21.
3
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.马卡丹特治疗有症状梗阻性肥厚型心肌病(EXPLORER-HCM):一项随机、双盲、安慰剂对照、3 期临床试验的健康状况分析。
Lancet. 2021 Jun 26;397(10293):2467-2475. doi: 10.1016/S0140-6736(21)00763-7. Epub 2021 May 15.
4
Molecular Genetic Basis of Hypertrophic Cardiomyopathy.肥厚型心肌病的分子遗传学基础。
Circ Res. 2021 May 14;128(10):1533-1553. doi: 10.1161/CIRCRESAHA.121.318346. Epub 2021 May 13.
5
Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.肌节和线粒体相关突变对肥厚型心肌病患者心肌纤维化的影响。
J Cardiovasc Magn Reson. 2021 Mar 4;23(1):18. doi: 10.1186/s12968-021-00718-3.
6
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death.肥厚型心肌病中心肌错构的致心律失常潜能:遗传基础、功能后果及与心源性猝死的关系。
Europace. 2021 Jul 18;23(7):985-995. doi: 10.1093/europace/euaa348.
7
Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.肌节和线粒体相关多基因变异对肥厚型心肌病表型的差异贡献。
Mitochondrion. 2020 Jul;53:48-56. doi: 10.1016/j.mito.2020.04.010. Epub 2020 May 4.
8
Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.肥厚型心肌病伴左心室收缩功能障碍:来自 SHaRe 注册研究的见解。
Circulation. 2020 Apr 28;141(17):1371-1383. doi: 10.1161/CIRCULATIONAHA.119.044366. Epub 2020 Mar 31.
9
Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.左心室应变在临床前和显性肥厚型心肌病中异常:心脏磁共振特征追踪。
Radiology. 2019 Mar;290(3):640-648. doi: 10.1148/radiol.2018180339. Epub 2018 Dec 18.
10
Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.基于心电图的肥厚型心肌病肥厚模式和纤维化程度预测:与心脏磁共振成像的对比研究。
Int J Cardiovasc Imaging. 2018 Oct;34(10):1619-1628. doi: 10.1007/s10554-018-1365-6. Epub 2018 May 4.